S-8 S-8 EX-FILING FEES 0001716947 Ensysce Biosciences, Inc. N/A Fees to be Paid 0001716947 2026-04-30 2026-04-30 0001716947 1 2026-04-30 2026-04-30 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

Ensysce Biosciences, Inc.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Common Stock, par value $0.0001 per share Other 828,749 $ 0.381 $ 315,753.37 0.0001381 $ 43.61

Total Offering Amounts:

$ 315,753.37

$ 43.61

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 43.61

Offering Note

1

Pursuant to Rules 457(c) and 457(h) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is the average of the high and low prices reported for the registrant's Common Stock quoted on The Nasdaq Capital Market LLC on April 27, 2026. Represents 828,749 additional shares reserved for issuance under the Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan, as amended (the "Plan"). Pursuant to Rule 416(a) under the Securities Act, this registration statement also covers an indeterminate number of additional shares as may be necessary to account for adjustment provisions under the Plan as a result of stock splits, stock dividends or similar transactions.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims
Fee Offset Sources